Powder: -20°C for 3 years | In solvent: -80°C for 1 year
beta-L-D4A is a nucleoside HIV-1 reverse transcriptase inhibitor. The biological activity of beta-L-D4A is connected with the termination of the DNA chain synthesis in the 5'-3' direction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | beta-L-D4A is a nucleoside HIV-1 reverse transcriptase inhibitor. The biological activity of beta-L-D4A is connected with the termination of the DNA chain synthesis in the 5'-3' direction. |
In vitro | beta-L-D4A is a nucleoside HIV-1 reverse transcriptase inhibitor. The results confirm the current belief that the biological activity of beta-L-D4A is connected with the termination of the DNA chain synthesis in the 5'-3' direction[1]. |
Synonyms | 2'3'-didehydro-2'3'-dideoxyadenosine |
Molecular Weight | 233.23 |
Formula | C10H11N5O2 |
CAS No. | 7057-48-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
beta-L-D4A 7057-48-9 2'3'-didehydro-2'3'-dideoxyadenosine inhibitor inhibit